Objective To evaluate the impact of infant growth on childhood health by examining the associations of detailed longitudinal infant weight velocity patterns with childhood cardiovascular and metabolic outcomes.
In a population-based prospective cohort study of 4649 children followed from fetal life onward, we examined associations of infant PWV, BMIAP, and AGEAP with childhood cardiovascular and metabolic outcomes, including blood pressure; left ventricular mass; total, high-density lipoprotein (HDL), and low-density lipoprotein (LDL) cholesterol concentrations; triglyceride levels; insulin concentration; and clustering of cardiovascular risk factors.
Methods
This study was embedded in the Generation R Study, a population-based prospective cohort study from early pregnancy onward in Rotterdam, The Netherlands. 15, 16 Of all eligible children in the study area, 61% participated in the study at birth. 15 The study protocol was approved by the local Medical Ethical Committee of Erasmus MC (MEC-2007-413) . Written informed consent was obtained from all mothers.
Infant growth measures were available for 6523 children who participated in the preschool phase of the study. We excluded 1797 children who did not have at least 3 infant growth measurements, required for infant growth modeling. Of the remaining 4726 children, 4681 participated in the follow-up studies at age 6 years. Cardiovascular and metabolic outcomes were measured in 4649 children (Figure; available at www.jpeds.com).
Gestational age-and sex-adjusted SDSs for birth weight and length were calculated using northern European growth charts. 17 Childhood length and weight were measured according to standardized procedures at birth and at age 1, 2, 3, 4, 6, 11, 14, 18, 24 , and 36 months. The median number of postnatal growth measurements was 5 (full range, [3] [4] [5] [6] [7] [8] [9] [10] [11] . 15 Age-and sex-adjusted SDS for all growth characteristics were obtained from Dutch reference growth charts. 18 As described previously, these growth measures were used to construct longitudinal weight and BMI growth patterns, and to derive infant PWV, AGEAP, and BMIAP values. 9, 10 In brief, infant PWV was derived using the Reed1 model for boys and girls separately. 19 The model was fitted by sex on all weight measurements recorded at age 0-3 years, including birth weight. The first derivative of the fitted distance curve was taken to obtain the weight velocity curve. To obtain the infant PWV, the maximum of this curve was taken. This value reflects the maximum rate of growth in infancy. For infant BMIAP, a cubic mixed-effects model was fitted on log(BMI) from age 14 days to 1.5 years, using sex as a covariate. Modeling of BMI growth was performed from age 14 days onward, because children can lose up to 10% of their body weight in the first 2 weeks of life. When fitting the model, age was centralized to 0.75 years. In addition to fixed effects, we included random effects for the constant and the slope in the model. Subsequently, BMI was derived for each individual at the point at which the curve reaches its maximum, which yields BMIAP and AGEAP.
Children visited our research center for follow-up measurements at a median age of 6 years (95% CI, 5.6-7.3 years). We measured blood pressure at the right brachial artery, 4 times at 1-minute intervals, using a validated automatic sphygmomanometer (Accutorr Plus; Datascope, Paramus, New Jersey). 20 We calculated the mean value using the last 3 blood pressure measurements for each participant. M-mode echocardiographic measurements were performed, and left ventricular mass was computed using the formula derived by Devereux. 21, 22 Intraobserver and interobserver intraclass correlation coefficients were calculated previously as 0.91-0.99 and 0.78-0.96, respectively. 23 Thirty-minute fasting blood samples were collected to measure cholesterol (total, HDL, and LDL), triglycerides, and insulin concentrations, using a cobas 8000 analyzer (Roche, Almere, The Netherlands). Quality control samples demonstrated intra-assay and interassay coefficients of variation of 0.77%-1.39% and 0.87%-2.40%, respectively.
We defined children with clustering of cardiovascular risk factors using the previously described definition of childhood metabolic syndrome phenotype, which means having 3 or more of the following components: android fat mass % ≥75th percentile; systolic or diastolic blood pressure ≥75th percentile, HDL cholesterol ≤ 25th percentile or triglycerides ≥75th percentile, and insulin level ≥75th percentile. 24 Percentiles were derived from the study population. We used android fat mass as percentage of total body fat mass, which served as proxy for waist circumference, which was not available. Total body fat mass and android fat mass were measured using a dualenergy X-ray absorptiometry (DXA) scanner (Lunar iDXA; GE Healthcare, Madison, Wisconsin) and analyzed with the enCORE software version 12.6. 25 Maternal age and prepregnancy BMI were recorded at study enrollment. Information on maternal educational level, smoking, alcohol consumption, and folic acid supplement use during pregnancy was obtained via questionnaire. 15 Information on gestational hypertensive disorders was obtained from midwife and hospital registries. 26 Child's ethnicity (European, non-European) was classified by the birth countries of the parents. At age 6 years, we measured height and weight and calculated BMI. We obtained sex-and age-specific SDS based on Dutch reference growth curves. 18
Statistical Analyses
First, we compared characteristics between boys and girls using one-way ANOVA, Kruskal-Wallace and c 2 tests. We also explored correlations between early growth measures and cardiovascular properties using Pearson correlation coefficients. Second, we assessed the associations of infant PWV, AGEAP, and BMIAP with childhood cardiovascular and metabolic outcomes using 2 multivariable linear regression models. The basic model was adjusted for child age and sex, whereas the confounder model was also adjusted for covariates selected based on their associations with the outcome of interest based on previous studies or a change in the effect estimate of >10%. For blood pressure and metabolic outcomes, we also created a third model controlling for current childhood BMI. Finally, we used logistic regression models to examine the associations of infancy PWV, AGEAP, and BMIAP with the risk of clustering of cardiovascular risk factors. We did not adjust these THE JOURNAL OF PEDIATRICS • www.jpeds.com Volume 186 analyses for multiple testing, because of the strong correlation between the different exposures and outcomes. Metabolic risk factors that were not normally distributed were log-transformed or root-transformed. We constructed SDSs (SDS = [observed value -mean/SD]) of determinants and metabolic outcomes. We constructed a height-adjusted SDS for blood pressure and body surface area-adjusted SDS for the left ventricular mass using generalized additive models for location, size, and shape using R version 3.2.0 (R Core Team, Vienna, Austria). [27] [28] [29] [30] We tested the interactions of PWV, AGEAP, and BMIAP with sex, ethnicity, and gestational age and weight at birth, in relation to cardiovascular variables. Because of the significant interaction between AGEAP and sex on systolic and diastolic blood pressure, we performed regression analyses stratified by sex. To reduce the possibility of potential bias associated with missing data, we imputed missing values in covariates using the multiple imputations procedure with 5 imputa-tions, and analyzed these datasets together. 31 Statistical analyses were performed using SPSS version 21.0 for Windows (IBM, Armonk, New York).
Results
Table I presents subject characteristics according to sex. Girls had lower infant PWV and BMIAP than boys (P < .01 for all). At age 6 years, boys had greater height, weight, and left ventricular mass, whereas girls had higher blood pressure, android fat mass percentage, total cholesterol and triglyceride concentrations, and percentage of clustering of cardiovascular risk factors (P < .05 for all). Subject characteristics before imputation are presented in Table II , whereas Tables III and IV (all available at www.jpeds.com) show Pearson correlation coefficients between infant PWV, AGEAP, and BMIAP and childhood cardiovascular and metabolic properties, respectively. (27) .01
Values represent the results based on imputed data. Characteristics based on original data are shown in Table II . Significant P values are in bold type. *Preeclampsia or pregnancy-induced hypertension. Table V shows that a 1-SDS increase in infant PWV was associated with higher diastolic blood pressure (0.06 SDS; 95% CI, 0.02-0.09), and lower left ventricular mass (−0.05 SDS; 95% CI, −0.09 to −0.01), independent of current body size. The positive association of PWV with systolic blood pressure was explained by current childhood BMI. A 1-SDS-higher infant BMIAP was associated with higher systolic blood pressure (0.12; 95% CI, 0.09-0.16) and diastolic blood pressure (0.05; 95% CI, 0.01-0.08), but these associations were explained by current childhood BMI. The associations of infant PWV and BMIAP with childhood blood pressure tended to be stronger in girls. Infant AGEAP was not associated with cardiovascular outcomes. Table VI (available at www.jpeds.com) shows results from the basic models adjusted for child's age and sex only.
Table VII (available at www.jpeds.com) shows in the models adjusted for current BMI that a 1-SDS-higher AGEAP was associated with lower triglyceride concentrations (−0.05 SDS; 95% CI, −0.10 to −0.01), and this association tended to be stronger in boys. Infant PWV and BMIAP were not associated with any of the metabolic outcomes. None of the infant growth patterns was associated with childhood LDL or HDL cholesterol concentrations or with LDL/total cholesterol ratio (data not shown). We did not observe any association between infant growth velocity patterns and metabolic properties in the basic models adjusted for child's age and sex (Table VIII; available at www.jpeds.com). 
Discussion
In this large population-based prospective cohort study, we observed that early infant growth velocity patterns are associated with certain cardiovascular outcomes, but not consistently with metabolic outcomes. The observed associations of infant growth patterns with childhood blood pressure tended to be Values are linear regression coefficients (95% CI) based on multiple linear regression models and reflect the change in outcome per SDS increase in each infant growth characteristics. Confounder model is adjusted for maternal factors: prepregnancy body mass index, educational level, smoking during pregnancy, use of alcohol during pregnancy, folic acid supplement use during pregnancy, systolic and diastolic blood pressure at intake, and gestational hypertensive disorders; and child factors: age, sex (total group), ethnicity, birth weight, and gestational age at birth. The BMI model for systolic and diastolic blood pressure was additionally adjusted for childhood BMI. Models adjusted for child's age and sex only are given in Table VI . For blood pressure, we used height-adjusted SDSs, whereas for left ventricular mass, we used body surface area-adjusted SDSs. P < .05 for interaction between AGEAP and sex on systolic and diastolic blood pressure. *P < .05. †P < .01. stronger in girls than in boys. Higher infant growth velocity patterns also were associated with an increased risk of clustering of cardiovascular risk factors.
The main strength of this study is its population-based prospective cohort design, including a large number of subjects studied from early fetal life onward. The repeated infant growth measures enabled us to study the effects of infant growth velocity patterns on the cardiovascular and metabolic properties. The study does have some limitations, however. Followup measurements were available in only 71% of the total group of singleton live-born children with information on growth. Loss to follow-up would lead to selection bias if the associations of early infant growth measures with childhood cardiovascular and metabolic measures differed between children included and those not included in the final analyses. 32 A limitation is that blood lipids and insulin concentrations were measured in blood samples collected in 30 minute-fasting states. According to studies in adults, fasting time has little influence on cholesterol levels, but concentrations of triglycerides and insulin vary more significantly with differences in fasting time. 33, 34 The measurement error for triglycerides and insulin levels in our study population could have led to nondifferential misclassification, which might have resulted in underestimation of our effect estimates for associations with triglycerides and insulin levels. Finally, although we adjusted for a large number of potential maternal and childhood confounders, residual confounding still might have occurred, as in any observational study.
A pattern of rapid growth in early life is associated with an increased risk of CVD in later life. 1 A study of 2285 Japanese adolescents aged 13-14 years showed that rapid weight gain during early childhood was predictive of high blood pressure and unfavorable lipid concentrations. 14 Moreover, data from 5 birth cohort studies showed an association between faster relative weight gain during early infant life and an increased risk of elevated blood pressure in adulthood. 35 In line with these studies, we found that early infant growth patterns are associated with cardiovascular variables in childhood. We did not find an association with metabolic variables, however.
Most previous studies used change in weight or length between 2 time points as an indicator of growth. More detailed infant growth patterns can be derived from the longitudinally collected anthropometric measures, such as PWV, BMIAP, and AGEAP. A previous study in Germany of 1127 children up to age 10 years found that higher PWV in infancy is associated with increased systolic and diastolic blood pressure after adjustment for confounders, including BMI 36 ; however, another cohort study of 2822 children in The Netherlands showed that the association of BMIAP with blood pressure at age 6 years was mediated by current BMI. 37 That same study found that the magnitude of peak BMI, not the timing of peak BMI, was more strongly associated with blood pressure. 37 In line with these studies, we observed an association of infant PWV and BMIAP with childhood blood pressure, which could be explained by current BMI. The association of infant PWV and BMIAP and diastolic blood pressure in our study was independent of current BMI in girls. Moreover, in the present study, infant AGEAP was not associated with childhood blood pressure.
Fetal and early-life growth patterns also may influence cardiac structure in children and adults. 38, 39 A previous study that examined the effect of early infant weight on left ventricular mass in 290 men born in East Hertfordshire, England, found that low weight at age 1 year was associated with higher left ventricular mass in adulthood. 39 In line with this study, we observed that higher PWV leads to lower left ventricular mass relative to current body size. A recent study suggests that fat mass is a minor predictor of left ventricular mass, whereas lean body mass is a much stronger predictor. 40 Therefore, the association between higher PWV and lower left ventricular mass might be explained by the different body composition of children with and without increased PWV relative to current body surface area.
Several previous studies have focused on the associations of infant weight gain with metabolic outcomes. A study of 1999 subjects found that a slower increase in BMI during the first 6 months after birth was associated with an atherogenic lipid profile in adult life. 41 An additional study among 396 men aged 58 years reported that the combination of being born small followed by a rapid weight gain was associated with the occurrence of risk factors included in the metabolic syndrome, and that growth patterns during infancy and childhood correlated with insulin levels later in life. 42 In our study, we only observed an inverse association of infant AGEAP with triglycerides concentrations after adjusting for current BMI. This observation was not consistent with other results and may be a chance finding. Our observation also may be explained by the strong positive association of BMI with triglycerides. Results from a study of 128 subjects suggest that rapid weight gain during infancy predicted clustering of metabolic risk factors at age 17 years. 43 Consistent with these results, our results show a greater risk of clustering of cardiovascular risk factors in children with higher PWV and AGEAP values. Thus, the increased risk for clustering seems driven mainly by increased blood pressure and adiposity, and not by the metabolic risk factors.
Although the observed effect estimates infant growth on cardiovascular and metabolic outcomes are small and without clinical relevance for individuals, the results from this study may be important on a population-based level. These results are especially important from an etiologic perspective and represent an important contribution to the field of developmental origins of cardiovascular disease. They suggest that infant growth influences cardiovascular development and might predispose individuals to cardiovascular disease in adulthood. We have shown that infant weight gain patterns may most importantly affect blood pressure and adiposity in childhood. Future research should focus on whether these changes in early childhood are associated with cardiovascular morbidity and mortality at later ages. ■ D uchenne muscular dystrophy is an X-linked, early-onset, and severely degenerative neuromuscular disease that affects 1 in 3500 live male births. It is characterized by delayed development of ambulation, progressive weakness in legs more than arms, pseudohypertrophy of the calves, and significantly elevated serum creatine kinase (CK) level. In the past, the diagnosis was made clinically, sometimes with the support of electromyography and muscle biopsy. Today, genetic testing focused on identifying deletions, duplications, and mutations in the dystrophin gene serves as the first step in diagnosing a patient with suspected Duchenne muscular dystrophy.
Fifty years ago, Thompson et al offered serum CK activity as a method of identifying female carriers of an affected dystrophin gene following the established diagnosis of a male family member. This was in a time before the discovery of the gene, and carriers were categorized as definite, probable, and possible based on pedigree analysis. Out of 200 females tested, all 24 with elevated CK activity were identified as carriers; however, a 35% false-negative rate was found. This was attributed to a combination of assay technique, skewed X-inactivation, germline mosaicism, and possible CK normalization with older age. Overall, elevated CK activity could be used to confirm carrier status, but a normal result could not exclude it.
Today, genetic testing, such as with hybridization arrays and sequencing, is the preferred method for diagnosis. Fol- 
